Growth Metrics

Biodesix (BDSX) Cash from Operations (2019 - 2026)

Biodesix filings provide 8 years of Cash from Operations readings, the most recent being 10168000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 18.21% to 10168000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 24837000.0, a 40.78% increase, with the full-year FY2025 number at 23271000.0, up 52.17% from a year prior.
  • Cash from Operations hit 10168000.0 in Q1 2026 for Biodesix, down from 778000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 937000.0 in Q2 2023 to a low of 18571000.0 in Q2 2024.
  • Median Cash from Operations over the past 5 years was 9594000.0 (2022), compared with a mean of 8819411.76.
  • Biggest five-year swings in Cash from Operations: tumbled 2081.96% in 2024 and later soared 118.99% in 2025.
  • Biodesix's Cash from Operations stood at 11948000.0 in 2022, then dropped by 2.8% to 12283000.0 in 2023, then soared by 66.65% to 4096000.0 in 2024, then soared by 118.99% to 778000.0 in 2025, then tumbled by 1406.94% to 10168000.0 in 2026.
  • The last three reported values for Cash from Operations were 10168000.0 (Q1 2026), 778000.0 (Q4 2025), and 8879000.0 (Q3 2025) per Business Quant data.